Clinical trialNCT02155660CompletedPhase 3Interventional

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

SponsorAstraZenecaEnrollment2,255Moderate to Very Severe Chronic Obstructive Pulmonary Disease

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Bartolome R. Celli, MD
Brigham and Women's Hospital, Pulmonary Division, 75 Francis Street, PBB Clinics 3, Boston, MA 02115
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

356 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
Buenos Aires, Argentina
Research Site
CABA, Argentina
Research Site
CABA, Argentina
Research Site
CABA, Argentina
Research Site
CABA, Argentina
Research Site
Ciudad Autónoma de Buenos Aire, Argentina
Research Site
Ciudad de Buenos Aires, Argentina
Research Site
Concepción del Uruguay, Argentina
Research Site
Corrientes, Argentina
Research Site
Córdoba, Argentina
Research Site
Córdoba, Argentina
Research Site
Florida, Argentina
Research Site
Mar del Plata, Argentina
Research Site
Mar del Plata, Argentina
Research Site
Mendoza, Argentina
Research Site
Mendoza, Argentina
Research Site
Nueve de Julio, Argentina
Research Site
Quilmes, Argentina
Research Site
Rosario, Argentina
Research Site
San Fernando, Argentina
Research Site
San Juan Bautista, Argentina
Research Site
San Miguel de Tucumán, Argentina

Australia

Research Site
Clayton, Australia
Research Site
Gosford, Australia
Research Site
Murdoch, Australia
Research Site
Nedlands, Australia
Research Site
New Lambton, Australia
Research Site
Woolloongabba, Australia

Belgium

Research Site
Brussels, Belgium
Research Site
Genk, Belgium
Research Site
Jambes, Belgium
Research Site
Leuven, Belgium
Research Site
Malmedy, Belgium
Research Site
Turnhout, Belgium
Research Site
Veurne, Belgium

Brazil

Research Site
Fortaleza, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Porto Alegre, Brazil

316 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 25 Jun 2014
Primary completion: 9 Apr 2018
Completion: 9 Apr 2018
Last update posted: 26 Jun 2019
Registered enrollment: 2,255
Registry id: NCT02155660

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.